Catalyst Wire Dossier Catalyst Wire Dossier

Endocrine therapy (class)

endocrine therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Endocrine therapy (class), covering 2025-05-16 to 2025-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management [Phase 4]

See pricing